Education
About Us
Working with TipRanks
Follow Us
Pfizer (GB:0Q1N)
LSE:0Q1N
Total Valuation
Pfizer has a market cap or net worth of $151.14B. The enterprise value is $217.54B.
Market Cap$151.14B
Enterprise Value$217.54B
Share Statistics
Pfizer has 5,686,267,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5,686,267,600
Owned by Insiders0.02%
Owned by Institutions11.82%
Financial Efficiency
Pfizer’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 8.84%.
Return on Equity (ROE)0.09
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)8.84%
Return on Capital Employed (ROCE)0.09
Revenue Per Employee772.58K
Profits Per Employee95.63K
Employee Count81,000
Asset Turnover0.30
Inventory Turnover1.74
Valuation Ratios
The current PE Ratio of Pfizer is 19.7. Pfizer’s PEG ratio is -4.31.
PE Ratio19.7
PS Ratio2.26
PB Ratio1.64
Price to Fair Value1.64
Price to FCF15.59
Price to Operating Cash Flow12.90
PEG Ratio-4.31
Income Statement
In the last 12 months, Pfizer had revenue of 62.58B and earned 7.77B in profits. Earnings per share was 1.36.
Revenue62.58B
Gross Profit44.01B
Operating Income15.44B
Pretax Income7.52B
Net Income7.77B
EBITDA15.10B
Earnings Per Share (EPS)1.36
Cash Flow
In the last 12 months, operating cash flow was 11.71B and capital expenditures -2.63B, giving a free cash flow of 9.08B billion.
Operating Cash Flow11.71B
Free Cash Flow9.08B
Free Cash Flow per Share1.60
Dividends & Yields
Pfizer pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.96
52-Week Price Change11.00%
50-Day Moving Average25.99
200-Day Moving Average24.39
Relative Strength Index (RSI)55.49
Average Volume (3m)114.61K
Important Dates
Pfizer upcoming earnings date is May 5, 2026, Before Open (Confirmed).
Last Earnings DateFeb 3, 2026
Next Earnings DateMay 5, 2026
Ex-Dividend Date―
Financial Position
Pfizer as a current ratio of 1.16, with Debt / Equity ratio of 77.96%
Current Ratio1.16
Quick Ratio0.87
Debt to Market Cap0.46
Net Debt to EBITDA4.39
Interest Coverage Ratio5.78
Taxes
In the past 12 months, Pfizer has paid -266.00M in taxes.
Income Tax-266.00M
Effective Tax Rate-0.04
Enterprise Valuation
Pfizer EV to EBITDA ratio is 13.76, with an EV/FCF ratio of 22.89.
EV to Sales3.32
EV to EBITDA13.76
EV to Free Cash Flow22.89
EV to Operating Cash Flow17.75
Balance Sheet
Pfizer has $13.60B in cash and marketable securities with $67.42B in debt, giving a net cash position of -$53.82B billion.
Cash & Marketable Securities$13.60B
Total Debt$67.42B
Net Cash-$53.82B
Net Cash Per Share-$9.46
Tangible Book Value Per Share-$6.73
Margins
Gross margin is 70.33%, with operating margin of 24.67%, and net profit margin of 12.42%.
Gross Margin70.33%
Operating Margin24.67%
Pretax Margin12.02%
Net Profit Margin12.42%
EBITDA Margin24.12%
EBIT Margin16.29%
Analyst Forecast
The average price target for Pfizer is $28.75, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$28.75
Price Target Upside5.65% Upside
Analyst ConsensusModerate Buy
Analyst Count23
Revenue Growth Forecast―
EPS Growth Forecast―